Cell therapy bioprocessing technologies and indicators of technological convergence

David A. Brindley; Anna L. French; Ricardo Baptista; Nick Timmins; Thorsten Adams; Ivan Wall; Kim Bure

Cell therapy bioprocessing technologies and indicators of technological convergence

David A. Brindley, Anna L. French, Ricardo Baptista, Nick Timmins, Thorsten Adams, Ivan Wall, Kim Bure

Research output: Contribution to specialist publication or newspaper › Article

Abstract

The cell therapy industry is undergoing a natural evolution from scientific curiosity into a commercially and clinically attractive opportunity (1). This evolution is by no means complete, and growing evidence suggests that its progression is driving significant developments in cell therapy bioprocessing — notably, convergence.

Original language	English
Pages	14-21
Number of pages	8
Volume	12
No.	3 SUPPL.
Specialist publication	BioProcess International
Publication status	Published - 1 Mar 2014

Cite this

@misc{3842b0d80f1148529bc7b9ea65a9434b,

title = "Cell therapy bioprocessing technologies and indicators of technological convergence",

abstract = "The cell therapy industry is undergoing a natural evolution from scientific curiosity into a commercially and clinically attractive opportunity (1). This evolution is by no means complete, and growing evidence suggests that its progression is driving significant developments in cell therapy bioprocessing — notably, convergence.",

author = "Brindley, {David A.} and French, {Anna L.} and Ricardo Baptista and Nick Timmins and Thorsten Adams and Ivan Wall and Kim Bure",

year = "2014",

month = mar,

day = "1",

language = "English",

volume = "12",

pages = "14--21",

journal = "BioProcess International",

issn = "1542-6319",

publisher = "PJB Publications Ltd.",

}

TY - GEN

T1 - Cell therapy bioprocessing technologies and indicators of technological convergence

AU - Brindley, David A.

AU - French, Anna L.

AU - Baptista, Ricardo

AU - Timmins, Nick

AU - Adams, Thorsten

AU - Wall, Ivan

AU - Bure, Kim

PY - 2014/3/1

Y1 - 2014/3/1

N2 - The cell therapy industry is undergoing a natural evolution from scientific curiosity into a commercially and clinically attractive opportunity (1). This evolution is by no means complete, and growing evidence suggests that its progression is driving significant developments in cell therapy bioprocessing — notably, convergence.

AB - The cell therapy industry is undergoing a natural evolution from scientific curiosity into a commercially and clinically attractive opportunity (1). This evolution is by no means complete, and growing evidence suggests that its progression is driving significant developments in cell therapy bioprocessing — notably, convergence.

UR - http://www.scopus.com/inward/record.url?scp=84898666648&partnerID=8YFLogxK

UR - https://bioprocessintl.com/upstream-processing/cell-culture-media/cell-therapy-bioprocessing-technologies-and-indicators-of-technological-convergence-350561/

M3 - Article

AN - SCOPUS:84898666648

SN - 1542-6319

VL - 12

SP - 14

EP - 21

JO - BioProcess International

JF - BioProcess International

ER -

Cell therapy bioprocessing technologies and indicators of technological convergence

Abstract

Other files and links

Fingerprint

Cite this